0001127602-20-008102.txt : 20200227
0001127602-20-008102.hdr.sgml : 20200227
20200227144549
ACCESSION NUMBER: 0001127602-20-008102
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200226
FILED AS OF DATE: 20200227
DATE AS OF CHANGE: 20200227
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: FOSTER JAMES C
CENTRAL INDEX KEY: 0001141722
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-15943
FILM NUMBER: 20661122
MAIL ADDRESS:
STREET 1: 251 BALLARDVALE ST
CITY: WILMINGTON
STATE: MA
ZIP: 01887
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
CENTRAL INDEX KEY: 0001100682
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 061397316
FISCAL YEAR END: 1228
BUSINESS ADDRESS:
STREET 1: 251 BALLARDVALE ST
CITY: WILMINGTON
STATE: MA
ZIP: 01887
BUSINESS PHONE: 781-222-6000
MAIL ADDRESS:
STREET 1: 251 BALLARDVALE ST
CITY: WILMINGTON
STATE: MA
ZIP: 01887
FORMER COMPANY:
FORMER CONFORMED NAME: CHARLES RIVER LABORATORIES INTERNATIONAL INC
DATE OF NAME CHANGE: 20000605
FORMER COMPANY:
FORMER CONFORMED NAME: CHARLES RIVER LABORATORIES HOLDINGS INC
DATE OF NAME CHANGE: 19991208
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2020-02-26
0001100682
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
CRL
0001141722
FOSTER JAMES C
251 BALLARDVALE STREET
WILMINGTON
MA
01887
1
1
Chairman, President and CEO
Common Stock
2020-02-26
4
M
0
25124
73.70
A
311899
D
Common Stock
2020-02-26
4
S
0
5311
160.398
D
306588
D
Common Stock
2020-02-26
4
S
0
4098
161.3973
D
302490
D
Common Stock
2020-02-26
4
S
0
6621
162.2099
D
295869
D
Common Stock
2020-02-26
4
S
0
4198
163.307
D
291671
D
Common Stock
2020-02-26
4
S
0
4896
164.1292
D
286775
D
Common Stock
12800
I
2018 GRAT
Common Stock
25000
I
2019 GRAT
Common Stock
750
I
By Trust
Common Stock
2250
I
By Trust
Common Stock
340
I
By Trust
Common Stock
10000
I
Held By Spouse
Stock Options (Right to Buy)
73.70
2020-02-26
4
M
0
25124
0
D
2017-02-26
2021-02-26
Common Stock
25124
0
D
This sale occurred pursuant to a 10b5-1 Trading Plan.
This transaction was executed in multiple trades at prices ranging from $159.84 to $160.825. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $160.85 to $161.82. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $161.84 to $162.79. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $162.85 to $163.785. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $163.80 to $164.79. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
/s/ James C. Foster
2020-02-27